Literature DB >> 8424203

Inoculation of peritoneal dialysate fluid into blood culture bottles improves culture rates.

B L Rayner1, D S Williams, S Oliver.   

Abstract

The aim of the study was to determine if direct inoculation of peritoneal fluid into Bactec blood culture bottles would improve the positive bacteriological yield compared with conventional techniques in continuous ambulatory peritoneal dialysis (CAPD) patients with peritonitis. All patients presenting with suspected peritonitis had peritoneal fluid injected directly into aerobic and anaerobic Bactec blood culture bottles as well as into sterile culture tubes. Thirty-seven paired samples were analysed. Twenty conventional cultures (54%) were positive compared with 33 (89%) done according to the Bactec system (P < 0.002). In only 1 case did the former technique prove superior. Direct inoculation of peritoneal fluid into Bactec blood culture bottles is therefore superior to conventional methods and has obvious therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8424203

Source DB:  PubMed          Journal:  S Afr Med J


  4 in total

1.  False-negative culture results with fungal isolates from peritoneal dialysis fluid.

Authors:  Jason D Pimentel; Gary D Lum
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

2.  Use of a pair of blood culture bottles for sterility testing of corneal organ culture media.

Authors:  P Gain; G Thuret; C Chiquet; A C Vautrin; A Carricajo; S Acquart; J Maugery; G Aubert
Journal:  Br J Ophthalmol       Date:  2001-10       Impact factor: 4.638

3.  Detecting bacterial growth in continuous ambulatory peritoneal dialysis effluent using two culture methods.

Authors:  Se-Hee Yoon; Nak Won Choi; Sung-Ro Yun
Journal:  Korean J Intern Med       Date:  2010-02-26       Impact factor: 2.884

4.  Sensitivity and rapidity of blood culture bottles in the detection of cornea organ culture media contamination by bacteria and fungi.

Authors:  G Thuret; A Carricajo; C Chiquet; A C Vautrin; N Celle; M Boureille; S Acquart; G Aubert; J Maugery; P Gain
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.